BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7503375)

  • 1. Involvement of interleukin-1 in middle ear cholesteatoma.
    Shiwa M; Kojima H; Kamide Y; Moriyama H
    Am J Otolaryngol; 1995; 16(5):319-24. PubMed ID: 7503375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin L activity and its inhibitor in human otitis media.
    Kusunoki T; Nishida S; Murata K; Kobashi K; Nakatani H; Hiwasa T; Tomura T
    J Otolaryngol; 2001 Jun; 30(3):157-61. PubMed ID: 11771045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of cytokines in cholesteatoma tissue.
    Marenda SA; Aufdemorte TB
    Otolaryngol Head Neck Surg; 1995 Mar; 112(3):359-68. PubMed ID: 7532849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
    Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock proteins in middle ear cholesteatoma.
    Shinoda H; Huang CC
    Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
    Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
    Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation activity and apoptosis in granulation tissue and cholesteatoma in middle ear reoperations.
    Durko M; Kaczmarczyk D
    Folia Morphol (Warsz); 2004 Feb; 63(1):119-21. PubMed ID: 15039916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear.
    Schilling V; Negri B; Bujía J; Schulz P; Kastenbauer E
    Am J Otol; 1992 Jul; 13(4):350-5. PubMed ID: 1384343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.
    Bujia J; Kim C; Ostos-Aumente P; Lopez-Villarejo J; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1997; 254(1):6-8. PubMed ID: 9115708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interleukin-1-containing cells in cholesteatoma of the middle ear].
    Schilling V; Bujia J; Negri B; Kastenbauer E
    Laryngorhinootologie; 1992 May; 71(5):271-5. PubMed ID: 1616549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biochemical studies of bone destruction in cholesteatoma.
    Amar MS; Wishahi HF; Zakhary MM
    J Laryngol Otol; 1996 Jun; 110(6):534-9. PubMed ID: 8763371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S; Satar B; Aydin N
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
    Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
    Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of chronic otitis media.
    Meyerhoff WL; Kim CS; Paparella MM
    Ann Otol Rhinol Laryngol; 1978; 87(6 Pt 1):749-60. PubMed ID: 570010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.
    Liu W; Xie S; Chen X; Rao X; Ren H; Hu B; Yin T; Xiang Y; Ren J
    Int J Clin Exp Pathol; 2014; 7(2):709-15. PubMed ID: 24551293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The roles of interleukin-1 alpha, tumor necrosis factor-alpha and parathyroid hormone-related protein in bone resorption of cholesteatoma otitis].
    Kinoshita K
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Aug; 97(8):1472-80. PubMed ID: 7931803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.